11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
NCT05608395
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma Multiforme
Interventions
DRUG:
11C-Methionine PET/CT
Sponsor
Masaryk Memorial Cancer Institute